can glp-1 be used in type 1 diabetes GLP-1-based therapies for 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Clinical Focus on GLP-1 Agonists

These drugs are also being approved for new indications, such as treatment for cardiovascular disease in overweight populations

Beran M, Estey E, O'Brien S, Cortes J, Koller CA, Giles FJ, Kornblau S, Andreeff M , Vey N, Pierce SR, Hayes K, Wong GC, Keating M, Kantarjian H

These agents include Rybelsus (oral semaglutide) and the novel first-in-class dual GIP/GLP-1 receptor agonist Mounjaro (tirzepatide), which is now available for use in the management of type 2 diabetes

Use this phase to establish structured eating, consistent training, and awareness of intake

This timeframe allows for cellular glutathione repletion, adaptation to injection routines, assessment of individual response patterns, and development of sustainable administration habits

Once absorbed, intracellular esterases cleave the acetyl group, releasing active GSH